We are live on ! Find out more
JGC

J. Goldman & Co Portfolio holdings

AUM $3.44B
1-Year Est. Return 33.8%
This Fund
S&P 500
This Quarter Est. Return
+6.67%
1 Year Est. Return
+33.8%
3 Year Est. Return
+89.45%
5 Year Est. Return
+82.14%
10 Year Est. Return
+407.39%
AUM
$844M
AUM Growth
-$811M
Cap. Flow
-$843M
Cap. Flow %
-99.83%
Top 10 Hldgs %
29.6%
Holding
364
New
95
Increased
32
Reduced
43
Closed
187

Top Sells

Rank Stock Value
1
JAH
JARDEN CORPORATION
JAH
+$25M
2
XLNX
Xilinx Inc
XLNX
+$20.1M
3
HSY icon
Hershey
HSY
+$17.2M
4
EL icon
Estee Lauder
EL
+$17M
5
ALTR
Altera Corp
ALTR
+$14.7M

Sector Composition

Rank Sector Weight
1 Healthcare 11.12%
2 Industrials 7.29%
3 Technology 6.69%
4 Communication Services 6.15%
5 Consumer Discretionary 5.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SLB icon
101
SLB Ltd
SLB
$76.5B
$2.64M 0.31%
+30,934
New +$2.85M
ACAS
102
DELISTED
American Capital Ltd
ACAS
$2.62M 0.31%
+179,580
New +$2.62M
GMAN
103
DELISTED
Gordmans Stores, Inc.
GMAN
$2.59M 0.31%
950,000
+250,000
+36% +$759K
KELYA icon
104
Kelly Services Class A
KELYA
$545M
$2.57M 0.3%
150,740
-86,677
-37% -$1.4M
DISH
105
DELISTED
DISH Network Corp.
DISH
$2.55M 0.3%
35,000
+7,060
+25% +$475K
BHI
106
DELISTED
Baker Hughes
BHI
$2.46M 0.29%
43,800
-93,700
-68% -$5.28M
LLL
107
DELISTED
L3 Technologies, Inc.
LLL
$2.38M 0.28%
+18,900
New +$2.26M
OIH icon
108
VanEck Oil Services ETF
OIH
$2.06B
$2.37M 0.28%
+3,300
New +$2.74M
KANG
109
DELISTED
iKang Healthcare Group, Inc.
KANG
$2.26M 0.27%
+150,000
New +$2.67M
COV
110
CALL
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
$2.25M 0.27%
22,000
+16,500
+300% +$1.58M
MGM icon
111
CALL
MGM Resorts International
MGM
$11.8B
$2.21M 0.26%
+103,600
New +$2.25M
EXPE icon
112
CALL
Expedia Group
EXPE
$33.4B
$2.19M 0.26%
25,700
+20,700
+414% +$1.76M
BSX icon
113
PUT
Boston Scientific
BSX
$67.6B
$2.19M 0.26%
+165,500
New +$2.12M
TCF
114
DELISTED
TCF Financial Corporation
TCF
$2.1M 0.25%
+132,000
New +$2.03M
ZTS icon
115
Zoetis
ZTS
$32.2B
$2.09M 0.25%
+48,666
New +$1.97M
BABA icon
116
Alibaba
BABA
$276B
$2.08M 0.25%
20,000
QUNR
117
DELISTED
Qunar Cayman Islands Limited
QUNR
$1.99M 0.24%
+70,000
New +$1.86M
RPRX
118
CALL
DELISTED
Repros Therapeutics Inc.
RPRX
$1.97M 0.23%
+197,500
New +$1.68M
AKS
119
CALL
DELISTED
AK Steel Holding Corp
AKS
$1.95M 0.23%
+327,200
New +$2.06M
AGN
120
PUT
DELISTED
Allergan Inc
AGN
$1.94M 0.23%
+9,100
New +$1.81M
AGN
121
DELISTED
Allergan plc
AGN
$1.89M 0.22%
7,342
-2,588
-26% -$647K
TXTR
122
DELISTED
TEXTURA CORPORATION COM
TXTR
$1.88M 0.22%
+66,040
New +$1.69M
HAPN
123
Happen Inc
HAPN
$2.16B
$1.83M 0.22%
+14,500
New +$1.83M
AVDL
124
DELISTED
Avadel Pharmaceuticals
AVDL
$1.77M 0.21%
+103,125
New +$1.47M
MAC icon
125
CALL
Macerich
MAC
$7.41B
$1.74M 0.21%
+20,900
New +$1.54M

Similar funds

J. Goldman & Co's Q4 2014 Portfolio in Review

As of Q4 2014, J. Goldman & Co held 364 positions worth $844M, down 49% from $1.66B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

J. Goldman & Co withdrew a net $843M in Q4 2014, closing 187 positions and reducing 43 holdings. Its most notable exit was JARDEN CORPORATION, an estimated $25M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 11% of assets, up from 5.6% a quarter earlier, followed by Industrials and Technology.

Against the trend, J. Goldman & Co opened a new position in Wright Medical Group Inc worth $9M.

  • J. Goldman & Co's largest Q4 2014 buy was Wright Medical Group Inc: 335,000 shares worth $9M.
  • J. Goldman & Co added most to Allergan Inc in Q4 2014, an estimated $18.5M increase.
  • J. Goldman & Co's biggest Q4 2014 reduction was Apple, cutting an estimated $14.1M.
  • J. Goldman & Co fully exited JARDEN CORPORATION in Q4 2014, selling an estimated $25M.
  • J. Goldman & Co's ten largest holdings make up 30% of its $844M portfolio in Q4 2014.
  • J. Goldman & Co opened 95 new positions and closed 187 in Q4 2014.
  • J. Goldman & Co's portfolio value fell 49% quarter-over-quarter to $844M.

Based on J. Goldman & Co's 13F filing for Q4 2014, filed 17 Feb 2015.